JP2023528476A - 組み換え微生物においてゲノムに安定に組み込むための方法 - Google Patents

組み換え微生物においてゲノムに安定に組み込むための方法 Download PDF

Info

Publication number
JP2023528476A
JP2023528476A JP2022574571A JP2022574571A JP2023528476A JP 2023528476 A JP2023528476 A JP 2023528476A JP 2022574571 A JP2022574571 A JP 2022574571A JP 2022574571 A JP2022574571 A JP 2022574571A JP 2023528476 A JP2023528476 A JP 2023528476A
Authority
JP
Japan
Prior art keywords
gene
microorganism
dna
seq
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022574571A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023528476A5 (https=
Inventor
ラウス ダン
ダブリュ．スターズル ティモシー
エス．ブイ．スターズル ラビ
Original Assignee
バイオピーエルエックス，インコーポレイティド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオピーエルエックス，インコーポレイティド filed Critical バイオピーエルエックス，インコーポレイティド
Publication of JP2023528476A publication Critical patent/JP2023528476A/ja
Publication of JP2023528476A5 publication Critical patent/JP2023528476A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6408—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/44—Staphylococcus
    • C12R2001/445—Staphylococcus aureus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21026—Prolyl oligopeptidase (3.4.21.26), i.e. proline-specific endopeptidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022574571A 2020-06-02 2021-06-02 組み換え微生物においてゲノムに安定に組み込むための方法 Pending JP2023528476A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063033681P 2020-06-02 2020-06-02
US63/033,681 2020-06-02
US202063049544P 2020-07-08 2020-07-08
US63/049,544 2020-07-08
PCT/US2021/035484 WO2021247729A1 (en) 2020-06-02 2021-06-02 Methods for stable genomic integration in recombinant microorganisms

Publications (2)

Publication Number Publication Date
JP2023528476A true JP2023528476A (ja) 2023-07-04
JP2023528476A5 JP2023528476A5 (https=) 2024-06-11

Family

ID=78829905

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022574571A Pending JP2023528476A (ja) 2020-06-02 2021-06-02 組み換え微生物においてゲノムに安定に組み込むための方法

Country Status (6)

Country Link
US (1) US20220025364A1 (https=)
EP (1) EP4158010A4 (https=)
JP (1) JP2023528476A (https=)
CA (1) CA3181274A1 (https=)
MX (1) MX2022015299A (https=)
WO (1) WO2021247729A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114015622A (zh) * 2021-12-14 2022-02-08 塔里木大学 无乳链球菌培养基及其制备方法
WO2024072985A1 (en) * 2022-09-28 2024-04-04 University Of Tennessee Research Foundation Polyvalent vaccines for staphylococcal & streptococcal infection
CN118858626B (zh) * 2024-09-20 2025-01-03 吉林大学 一种用于检测血浆金黄色葡萄球菌抗体的检测试剂、试剂盒及方法
CN119162219B (zh) * 2024-09-24 2025-08-12 湖北大学 过表达perR基因在提高苏云金芽胞杆菌生物锰氧化作用中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100190160A1 (en) * 2007-01-24 2010-07-29 Shriners Hospitals For Children Indicator cell lines and methods for making same
WO2019113096A1 (en) * 2017-12-05 2019-06-13 BioPlx, Inc. Methods and compositions to prevent microbial infection

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003269379A1 (en) * 2002-10-31 2004-05-25 Pfizer Products Inc. Suspension method for producing embryoid bodies, and compositions and methods related thereto
EP1524320A1 (en) * 2003-10-15 2005-04-20 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Rapid determination and quantification of mycoplasma contamination using DNA chip technology
US20060260004A1 (en) * 2004-04-01 2006-11-16 Yiwen Fang Par-related protein promoters
US7674621B2 (en) * 2004-05-21 2010-03-09 The United States Of America As Represented By The Department Of Health And Human Services Plasmids and phages for homologous recombination and methods of use
MX2007010008A (es) * 2005-02-16 2008-01-18 Lentigen Corp Vectores lentivirales y su uso.
CN101300356A (zh) * 2005-09-09 2008-11-05 基因组股份公司 用于琥珀酸盐之生长关联性生产的方法和生物
KR20090023464A (ko) * 2006-06-08 2009-03-04 가부시키가이샤 아미노 압 가가쿠 유전자 산물의 생산량을 제어하는 방법 및 생산량 제어제
WO2013016427A1 (en) * 2011-07-25 2013-01-31 Alvine Pharmaceuticals, Inc. Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance
EP3355939A4 (en) * 2015-09-30 2019-04-17 Trustees of Boston University MICROBIAL DEADMAN AND PASS CODE EMERGENCY STOP SWITCHES
WO2017123676A1 (en) * 2016-01-11 2017-07-20 Synlogic, Inc. Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
CA3146363A1 (en) * 2019-07-08 2021-01-14 BioPlx, Inc. Live biotherapeutic compositions and methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100190160A1 (en) * 2007-01-24 2010-07-29 Shriners Hospitals For Children Indicator cell lines and methods for making same
WO2019113096A1 (en) * 2017-12-05 2019-06-13 BioPlx, Inc. Methods and compositions to prevent microbial infection

Also Published As

Publication number Publication date
MX2022015299A (es) 2023-03-13
EP4158010A1 (en) 2023-04-05
CA3181274A1 (en) 2021-12-09
EP4158010A4 (en) 2025-02-19
WO2021247729A1 (en) 2021-12-09
US20220025364A1 (en) 2022-01-27

Similar Documents

Publication Publication Date Title
US20250346910A1 (en) Methods and compositions to prevent microbial infection
O’Sullivan et al. Nisin J, a novel natural nisin variant, is produced by Staphylococcus capitis sourced from the human skin microbiota
Colomer-Winter et al. Manganese acquisition is essential for virulence of Enterococcus faecalis
Hecht et al. Strain competition restricts colonization of an enteric pathogen and prevents colitis
JP2023528476A (ja) 組み換え微生物においてゲノムに安定に組み込むための方法
Chouikha et al. Silencing urease: a key evolutionary step that facilitated the adaptation of Yersinia pestis to the flea-borne transmission route
Garrido et al. Engineering a genome‐reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo
US20220288135A1 (en) Live biotherapeutic compositions and methods
US20180371405A1 (en) Methods and compositions for delivery of crispr based antimicrobials
Zhu et al. Gene fitness landscape of group A streptococcus during necrotizing myositis
Jiang et al. Role of Efflux Pumps in the in vitro Development of Ciprofloxacin Resistance in Listeria monocytogenes
Hiller et al. Puzzling over the pneumococcal pangenome
Whitby et al. Haemophilus influenzae OxyR: characterization of its regulation, regulon and role in fitness
Wichgers Schreur et al. Lysozyme resistance in Streptococcus suis is highly variable and multifactorial
Lawrence et al. Nisin G is a novel nisin variant produced by a gut-derived Streptococcus salivarius
Lawrence et al. A gut-derived Streptococcus salivarius produces the novel nisin variant designated nisin G and inhibits Fusobacterium nucleatum in a model of the human distal colon microbiome
Franklin et al. A bacteriophage-conditional mouse model reveals the impact of phages within a conventionally colonized gut microbiota
Chen et al. Involvement of the Actinobacillus pleuropneumoniae ompW gene in confrontation of environmental pressure
Lam et al. Genome-wide analysis of Enterococcus faecalis genes that facilitate interspecies competition with Lactobacillus crispatus
Cao et al. Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vector
Amat et al. The Bovine Ocular Microbiome: A Multi-Approach Study of Composition and Antimicrobial Activity
Ma et al. A surface protein identified from Streptococcus suis serotype 2 exhibits neutrophil-resistant ability via its polysaccharide capsule
Zhu et al. Investigation of choline-binding protein of CbpD in the pathogenesis of Streptococcus suis type 2
Antezana Horizontal Transfer of Antibiotic Resistance in Streptococcus pneumoniae
Xu et al. pleuropneumoniae isolate disseminating the floR resistance gene to Enterobacteriaceae

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240603

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240603

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250805

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20251104

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20260303